Total Payments
$548.16
2020 Payments
$41.96
Companies
2
Transactions
30
Medicare Patients
328
Medicare Billing
$32,928
Payment Breakdown by Category
Food & Beverage$548.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $548.16 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $469.02 | 25 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $79.14 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $41.96 | 3 | Sun Pharmaceutical Industries Inc. ($28.37) |
| 2019 | $239.78 | 17 | Allergan Inc. ($189.01) |
| 2018 | $219.25 | 8 | Allergan Inc. ($219.25) |
| 2017 | $47.17 | 2 | Allergan Inc. ($47.17) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/11/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Ophthalmology | ||||||
| 03/25/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/17/2020 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Ophthalmology | ||||||
| 12/20/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/09/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Ophthalmology | ||||||
| 12/05/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/01/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/04/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/27/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/09/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/27/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/21/2019 | Allergan Inc. | DALIRESP (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/16/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/03/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/07/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/28/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/21/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Ophthalmology | ||||||
| 01/21/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: Ophthalmology | ||||||
| 11/30/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/12/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/14/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/04/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $90.03 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 102 | 102 | $57,856 | $8,169 |
| 2021 | 4 | 89 | 91 | $76,908 | $7,976 |
| 2020 | 6 | 137 | 138 | $141,600 | $16,783 |
Total Patients
328
Total Services
331
Medicare Billing
$32,928
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 35 | 35 | $51,730 | $5,251 | 10.2% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 21 | 21 | $2,150 | $1,014 | 47.1% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 18 | 18 | $1,800 | $869.09 | 48.3% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 12 | 12 | $1,200 | $579.72 | 48.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 16 | $976.00 | $455.06 | 46.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 44 | 44 | $62,104 | $6,350 | 10.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 12 | 12 | $11,955 | $1,204 | 10.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 14 | $854.00 | $374.15 | 43.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 19 | 21 | $1,995 | $47.25 | 2.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 77 | 78 | $104,486 | $11,327 | 10.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 11 | 11 | $19,662 | $2,098 | 10.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $4,800 | $1,355 | 28.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 11 | 11 | $10,307 | $1,059 | 10.3% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 11 | 11 | $1,430 | $558.23 | 39.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 15 | 15 | $915.00 | $385.12 | 42.1% |
About Dr. Roger Wu, M.D
Dr. Roger Wu, M.D is a Emergency Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1801156799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Wu, M.D has received a total of $548.16 in payments from pharmaceutical and medical device companies, with $41.96 received in 2020. These payments were reported across 30 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($548.16).
As a Medicare-enrolled provider, Wu has provided services to 328 Medicare beneficiaries, totaling 331 services with total Medicare billing of $32,928. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Providence, RI
- Active Since 05/24/2012
- Last Updated 05/24/2012
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801156799
Products in Payments
- DALVANCE (Drug) $345.62
- TEFLARO (Drug) $65.68
- BROMSITE (Drug) $49.92
- CEQUA (Drug) $29.22
- BYSTOLIC (Drug) $24.66
- LINZESS (Drug) $22.51
- DALIRESP (Drug) $10.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Providence
Michael Waxman, Md, MD
Emergency Medicine — Payments: $73,697
Emergency Medicine $73,697
Arun Nagdev, Md, MD
Emergency Medicine — Payments: $19,389
Emergency Medicine $19,389
Roland Merchant, Md, MD
Emergency Medicine — Payments: $12,573
Emergency Medicine $12,573
Dr. Francesca Beaudoin, M.d, M.D
Emergency Medicine — Payments: $10,985
Emergency Medicine $10,985
Eliot Jekowsky, Md, MD
Emergency Medicine — Payments: $9,997
Emergency Medicine $9,997
Dr. Christopher Mccarthy, M.d, M.D
Emergency Medicine — Payments: $4,536
Emergency Medicine $4,536